PCM
SOPH icon

Perkins Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Perkins Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Hold
10,500
– – 0.05% 76
2026
Q1 		$52K Hold
10,500
– – 0.05% 84
2025
Q4 		$49K Buy
+10,500
New +$47.6K 0.04% 89

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Perkins Capital Management's SOPH Position: Q2 2026 in Review

Perkins Capital Management held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 10,500 shares worth $60.6K. The position accounts for 0.05% of the portfolio, ranked #76.

Perkins Capital Management first reported a position in SOPH in Q4 2025 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Perkins Capital Management held 10,500 shares of SOPHiA GENETICS worth $60.6K as of Q2 2026.
  • Perkins Capital Management left its SOPHiA GENETICS share count unchanged in Q2 2026.
  • SOPHiA GENETICS made up 0.05% of Perkins Capital Management's portfolio in Q2 2026, its #76 holding.
  • Perkins Capital Management first reported a position in SOPHiA GENETICS in Q4 2025 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.